Author archives: CHRIS MARKOCH

If you’re an investor with a long-term outlook, this article looks at whether there is value in buying Winnebago stock after the company’s earnings report

JNJ stock is seen as a defensive play which has typically done well in bear markets. But there is one issue that makes longer-term forecasts uncertain

Despite the potential benefits, the proposed Kroger/Albertsons merger faces regulatory scrutiny. Is now the time to invest in either of the two companies

At a time when investors are seeking value wherever they can find it, UnitedHealth Group is offering investors both growth and value

Walgreen’s Boots Alliance is up sharply after posting a double beat. But with growth remaining sluggish, this current bump in WBA stock mayl be short lived

Macroeconomic realities are weighing on the near-term outlook for all EV companies. This article will examine if you should continue to hold onto Lucid Motors

Will Rite Aid stock ever recover? Unless Rite Aid can improve its revenue, the best advice for investors may involve staying away from the stock.

A steep decline in CarMax profits shows that a more efficient way to sell cars is not enough to overcome higher prices that are keeping consumers away

Investors may be debating if they should hold TGT stock during this market downturn. This article explains why long-term investors may want to do just that

NVAX is a risk-on stock at a time investors are turning to risk-off assets. This article looks to see if Novavax still presents an opportunity for investors